Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Clinician's Roundtable

Can Social Networking Revolutionize Disease Management?

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    For over a decade, patients have been turning to the Internet for health information and support. At least one new online venture gives patients the opportunity to access data about medications and therapies and their effects and outcomes. But this isn't clinical trial data. This is detailed, highly quantified, "real-world" data that patients put on the social networking site Patients Like Me about themselves, in order to connect with others who share their disease and learn from their experiences. Co-founder and chairman Jamie Heywood, a graduate of MIT, talks to host Bruce Japsen about privacy, doctor-patient communication, conflict of interest, and the potential effect on pharmaceutical development of giving patients the opportunity to review their treatments.

Recommended
Details
Presenters
Comments
  • Overview

    For over a decade, patients have been turning to the Internet for health information and support. At least one new online venture gives patients the opportunity to access data about medications and therapies and their effects and outcomes. But this isn't clinical trial data. This is detailed, highly quantified, "real-world" data that patients put on the social networking site Patients Like Me about themselves, in order to connect with others who share their disease and learn from their experiences. Co-founder and chairman Jamie Heywood, a graduate of MIT, talks to host Bruce Japsen about privacy, doctor-patient communication, conflict of interest, and the potential effect on pharmaceutical development of giving patients the opportunity to review their treatments.

Schedule10 Oct 2024